Glyphic Biotechnologies
Latest round
- Seed
Last raised
- Jul 2021
Total raised
- $6M
Investors
- 7
About Glyphic Biotechnologies
Based in California, US, and founded in 2021, Glyphic Biotechnologies, Inc. operates as a biotechnology company that sequences proteins. The company was co-founded by CEO Mr. Joshua Yang and CTO Mr. Daniel Estandian. In February 2024, Glyphic Biotechnologies, Inc.
Who invested in Glyphic Biotechnologies
7 investors across 1 round
See all investors in Glyphic Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 8, 2021
Amount
$6M
Investors
Questions about Glyphic Biotechnologies
Who invested in Glyphic Biotechnologies?
Glyphic Biotechnologies has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Glyphic Biotechnologies raised?
Glyphic Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Glyphic Biotechnologies last raise money?
Glyphic Biotechnologies's most recent round on record is a Seed, in Jul 2021.
What does Glyphic Biotechnologies do?
Based in California, US, and founded in 2021, Glyphic Biotechnologies, Inc.
Where is Glyphic Biotechnologies headquartered?
Glyphic Biotechnologies is headquartered in Berkeley, US.
Which VCs invest in companies like Glyphic Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Glyphic Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Glyphic Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.